Publications

Junior market detractors should AIM criticisms elsewhere

By Neil Matthews and Jonathan Brooks | 14 Jan 2019

Fieldfisher responds to article in the Sunday Times regarding the number of AIM-listed company insolvencies in 2018.

NHS Consultation response: developing the long-term plan for the NHS

By Sarah Ellson, Beatriz San Martín, Justyna M. Ostrowska and Marta Dunphy-Moriel | 15 Nov 2018

Dirty laundry: Do British businesses risk being tarnished by new EU anti-money laundering rules post-Brexit?

By Francesca Titus and Elliott Kenton | 05 Oct 2018

Fieldfisher corporate crime partner Francesca Titus and corporate crime associate Elliott Kenton discuss how moves to tighten up EU AML legislation could side-line UK companies.

Nouvelles méthodologies de référence publiées par la CNIL : quel impact sur les notes d'information à délivrer aux patients dans le cadre des essais cliniques ?

By Olivier Lantrès and Sébastien Pradeau | 19 Jul 2018

New reference documents published by the French data protection authority (CNIL): what impact on information notes to be delivered to patients in clinical trials?

Le Conseil d'Etat se prononce en faveur d'une plus grande communication des professionnels de santé à destination du public : quel en sera l'impact pour les industriels du secteur ?

By Olivier Lantrès and Sébastien Pradeau | 02 Jul 2018

The Conseil d'Etat is in favour of greater communication by healthcare professionals to the public: what impact will this have on manufacturers in the sector?

Infraction à la loi "anti-cadeaux" : la Cour de cassation confirme l'arrêt de la cour d'appel de Paris ayant prononcé l'an dernier des amendes records

By Olivier Lantrès and Sébastien Pradeau | 12 Jun 2018

Violation of the "anti-kickback" statute: the French Supreme Court upholds the 2017 decision of the Paris Court of Appeal imposing record fines

US v Russia Sanctions Crossfire – How is your business affected?

By Vivien Davies and Vanessa Wilkinson | 23 Apr 2018

The past few weeks have seen the introduction of new sanctions against Russia by the US, the scope of which extends to non-US persons.

An alternative to patents: can DNA be protected by copyright and design right law?

By Beatriz San Martín and Heidi Hurdle | 20 Apr 2018

Responsabilité du fait des produits défectueux et médicament : Un patient peut rechercher la responsabilité d'un industriel de la santé dans les dix ans de la consolidation du dommage

By Olivier Lantrès and Sébastien Pradeau | 16 Apr 2018

Liability due to defective products and medication: A patient can search for the responsibility of an industrialist of health within ten years of damage consolidation